Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog
- PMID: 9815144
- DOI: 10.1161/01.res.83.10.969
Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog
Abstract
The aim of the present study was to determine whether cardiac nitric oxide (NO) production changes during the progression of pacing-induced heart failure and whether this occurs in association with alterations in myocardial metabolism. Dogs (n=8) were instrumented and the heart paced until left ventricular end-diastolic pressure reached 25 mm Hg and clinical signs of severe failure were evident. Every week, hemodynamic measurements were recorded and blood samples were withdrawn from the aorta and the coronary sinus for measurement of NO metabolites, O2 content, free fatty acids (FFAs), and lactate and glucose concentrations. Cardiac production of NO metabolites or consumption of O2 or utilization of substrates was calculated as coronary sinus-arterial difference times coronary flow. In end-stage failure, occurring at 29+/-1.6 days, left ventricular end-diastolic pressure was 25+/-1 mm Hg, left ventricular systolic pressure was 92+/-3 mm Hg, mean arterial pressure was 75+/-2.5 mm Hg, and dP/dtmax was 1219+/-73 mm Hg/s (all P<0.05). These changes in hemodynamics were associated with a fall of cardiac NO metabolite production from 0.37+/-0.16 to -0.28+/-0.13 nmol/beat (P<0.05). O2 consumption and lactate uptake did not change significantly from control, while FFA uptake decreased from 0.16+/-0.03 to 0.05+/-0.01 microEq/beat and glucose uptake increased from -2.3+/-7.0 to 41+/-10 microgram/beat (P<0.05). The cardiac respiratory quotient also increased significantly by 28%. In 14 normal dogs the same measurements were performed at control and 1 hour after we injected 30 mg/kg of nitro-L-arginine, a competitive inhibitor of NO synthase .O2 consumption increased from 0.05+/-0.002 mL/beat at control to 0.071+/-0.003 mL/beat after nitro-L-arginine, while FFA uptake decreased from 0.1+/-0.01 to 0.06+/-0.01 microEq/beat, lactate uptake increased from 0.15+/-0.04 to 0.31+/-0.03 micromol/beat, glucose uptake increased from 8.2+/-5.0 to 35.4+/-9.5 microgram/beat, and RQ increased by 23% (all P<0.05). Our results indicate that basal cardiac production of NO falls below normal levels during cardiac decompensation and that there are shifts in substrate utilization. This switch in myocardial substrate utilization also occurs after acute pharmacological blockade of NO production in normal dogs.
Comment in
-
Nitric oxide, myocardial oxygen consumption, and ATP synthesis.Circ Res. 1998 Nov 16;83(10):1067-8. doi: 10.1161/01.res.83.10.1067. Circ Res. 1998. PMID: 9815154 No abstract available.
Similar articles
-
Shift in metabolic substrate uptake by the heart during development of alloxan-induced diabetes.Am J Physiol Heart Circ Physiol. 2003 Sep;285(3):H1007-14. doi: 10.1152/ajpheart.00528.2002. Am J Physiol Heart Circ Physiol. 2003. PMID: 12915387
-
Role of nitric oxide in the regulation of substrate metabolism in heart failure.Heart Fail Rev. 2002 Apr;7(2):141-8. doi: 10.1023/a:1015324508556. Heart Fail Rev. 2002. PMID: 11988638 Review.
-
Mechanisms whereby rapid RV pacing causes LV dysfunction: perfusion-contraction matching and NO.Am J Physiol Heart Circ Physiol. 2001 Dec;281(6):H2270-81. doi: 10.1152/ajpheart.2001.281.6.H2270. Am J Physiol Heart Circ Physiol. 2001. PMID: 11709392
-
The role of nitric oxide in the failing heart.Heart Fail Rev. 2001 Mar;6(2):105-18. doi: 10.1023/a:1011453809750. Heart Fail Rev. 2001. PMID: 11309529 Review.
-
Nitric oxide controls cardiac substrate utilization in the conscious dog.Cardiovasc Res. 1999 Nov;44(2):325-32. doi: 10.1016/s0008-6363(99)00245-x. Cardiovasc Res. 1999. PMID: 10690309
Cited by
-
Metabolic mechanisms in physiological and pathological cardiac hypertrophy: new paradigms and challenges.Nat Rev Cardiol. 2023 Dec;20(12):812-829. doi: 10.1038/s41569-023-00887-x. Epub 2023 May 26. Nat Rev Cardiol. 2023. PMID: 37237146 Review.
-
Derangements and Reversibility of Energy Metabolism in Failing Hearts Resulting from Volume Overload: Transcriptomics and Metabolomics Analyses.Int J Mol Sci. 2022 Jun 18;23(12):6809. doi: 10.3390/ijms23126809. Int J Mol Sci. 2022. PMID: 35743252 Free PMC article.
-
Evidence of altered fatty acid metabolism in dogs with naturally occurring valvular heart disease and congestive heart failure.Metabolomics. 2022 May 30;18(6):34. doi: 10.1007/s11306-022-01887-7. Metabolomics. 2022. PMID: 35635592 Free PMC article.
-
Deranged Myocardial Fatty Acid Metabolism in Heart Failure.Int J Mol Sci. 2022 Jan 17;23(2):996. doi: 10.3390/ijms23020996. Int J Mol Sci. 2022. PMID: 35055179 Free PMC article. Review.
-
Iron deficiency as an emerging therapeutic target in patients stabilized after an episode of acute heart failure.Cardiol J. 2021;28(6):962-969. doi: 10.5603/CJ.a2021.0165. Epub 2021 Dec 13. Cardiol J. 2021. PMID: 34897633 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical